A significant rotation is underway in equity markets, with investors moving capital from AI-heavy technology stocks into healthcare, industrials, and traditional value sectors. The shift has accelerated over the past month as questions about AI revenue timelines mount. [1]

The rotation reflects a growing skepticism about the gap between AI investment and revenue generation. While hyperscalers have committed hundreds of billions to AI infrastructure, the revenue from AI applications has not yet matched the investment. Investors are repositioning for a scenario where AI's returns take longer than expected. [1]

Healthcare and medical device companies have been primary beneficiaries. The sector offers predictable revenue streams and recession-resistant demand — qualities that have become more attractive as AI company valuations face scrutiny. [2]

The rotation is not yet a stampede. AI-related stocks still represent significant portfolio holdings, and many institutional investors maintain long-term positions. But the flow data suggests a meaningful reassessment of the AI trade's risk-reward profile. [2]

The market's rotation is ultimately a pricing mechanism. It reflects the collective judgment that AI's promise is real but its timeline is uncertain — and that other sectors offer better near-term value.

-- THEO KAPLAN, San Francisco